Skip to Content

93 5514 93 5514 (Carbamazepine extended-release 300 mg)

Pill with imprint 93 5514 93 5514 is Green / Black, Capsule-shape and has been identified as Carbamazepine extended-release 300 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Carbamazepine is used in the treatment of trigeminal neuralgia; schizoaffective disorder; bipolar disorder; borderline personality disorder; epilepsy (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 93 5514 93 5514

Carbamazepine extended-release

Imprint:
93 5514 93 5514
Strength:
300 mg
Color:
Green / Black
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
Inactive Ingredients:
carnauba wax
D&C Yellow No. 10
FD&C Green No. 3
gelatin
ferrosoferric oxide
lactose monohydrate
polyethylene glycol 1450
propylene glycol
shellac
sodium lauryl sulfate
sorbitan monolaurate
titanium dioxide
povidone
sodium hydroxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide